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Abstract
It has been reported that the fusion protein with the protein transduction domain (PTD) peptide of HIV-1 Tat protein can
be internalized through the cell membrane of intact cells, although the exact mechanism is unknown. In this report, we
investigated whether this new method could be used for the molecular analysis of exocytosis via HPC-1/syntaxin 1A, which
plays an important role in transmitter release. When applied to PC12 cells, Tat PTD fusion proteins were rapidly internalized
into most cells. In order to show that the internalized protein remained biologically active, the H3 domain of HPC-1/syntaxin
1A was fused to Tat PTD (Tat-H3). Transmitter release in PC12 cells was suppressed by Tat-H3 treatment. These results
indicate that the Tat fusion protein is a useful tool for analyzing the process of transmitter release. ß 2001 Elsevier Science
B.V. All rights reserved.
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1. Introduction
HPC-1/syntaxin 1A plays an important role in
exocytosis [1^3]. This protein binds to synaptoso-
mal-associated protein of 25 kDa (SNAP-25) and
vesicle-associated membrane protein (VAMP2),
forming a stable complex called the SNARE complex
(soluble N-ethylmaleimide sensitive fusion protein at-
tachment protein receptor complex) [4]. It is thought
that assembly or disassembly of this stable complex
occurs during the process of intracellular membrane
fusion. It is well known that one of the K-helical
structural regions of HPC-1/syntaxin 1A, called the
H3 domain, contributes to SNARE complex forma-
tion. Although it is also known that this domain is
essential for binding to other SNAREs [5], the exact
mechanism of transmitter release via SNARE is not
yet clear.
In order to understand the intracellular molecular
mechanism of exocytosis in detail, many experiments
using living cells have been performed. For example,
digitonin and streptolysin-O permeabilized cells have
been used to introduce macromolecules, including
proteins, into cells [6]. However, it is thought that
permeabilized cells may di¡er from intact cells, since
the cells become leaky or fragile. During microinjec-
tion into an intact cell, it is di⁄cult to control the
concentrations of the injected reagents in the cell.
Recently, it was reported that the L-galactosidase
fusion protein with the protein transduction domain
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(PTD) peptide of HIV-1 Tat protein could be inter-
nalized through the cell membranes of intact cells
[7,8]. Tat PTD peptide chemically crosslinked with
horseradish peroxidase (HRP) or IgG has also been
internalized into many types of cells [9,10]. However,
this has not been used to analyze the process of
exocytosis.
This report shows that the Tat PTD method using
Tat-H3 fusion protein can be a useful tool for the
molecular analysis of the process of transmitter re-
lease. Furthermore, we show that the suppressive ef-
fect of Tat-H3 treatment is accelerated by prestimu-
lation.
2. Experimental procedure
2.1. Antibodies
IgG was puri¢ed from normal rabbit serum with
protein A Sepharose (Amersham Pharmacia Bio-
tech). Anti-H3 antibody was raised against recombi-
nant protein as reported [11]. The speci¢city of this
antiserum was examined by immunoblotting with rat
brain homogenate (data not shown). Anti-His tag
antibody was purchased from Santa Cruz Biotech-
nology.
2.2. Plasmid construct
A double stranded oligonucleotide encoding Tat
PTD peptide (GYGRKKRRQRRRG) was ligated
with a green £uorescence protein (GFP) cDNA frag-
ment. This fragment was subcloned into pPRo Ex-1
vector (Gibco BRL). HPC-1/syntaxin 1A cDNA
fragments were prepared by PCR. The PCR frag-
ments encoding N265 (1^265), N201 (1^201), N97
(1^97), and H3 (202^265) were replaced with GFP
cDNA from the Tat-GFP vector.
2.3. Protein expression and peptide conjugated protein
preparation
All recombinant proteins were produced in Esche-
richia coli DH5K cells by induction with 1 mM
IPTG. These recombinant proteins (His tag fusion
proteins) were extracted with 8 M urea solution con-
taining 100 mM NaCl and 20 mM HEPES (pH 8.0).
The extracts were loaded on a Ni-agarose column.
Recombinant proteins were eluted with bu¡er solu-
tion containing 200 mM imidazole. The puri¢ed re-
combinant proteins were desalted on a PD-10 col-
umn (Amersham Pharmacia Biotech) into Hanks’
balanced salt solution (HBSS) and applied to culture
medium.
IgG was dissolved in 0.1 M borate bu¡er (pH 8.5)
at 5 mg/ml and incubated with a 5^10-fold molar
excess of sulfosuccinimidyl-6-[3P-(2-pyridyldithio)-
propionamido]hexanonate (slcSPDP Pierce) for 3 h
at 25‡C. After dialysis against phosphate-bu¡ered
saline (PBS), the reaction product was incubated
with a 3-fold molar excess of Tat PTD peptide for
24 h at 4‡C. Finally, the peptide conjugated IgG was
dialyzed against HBSS.
2.4. Immunohistochemistry
PC12 cells were maintained in DMEM (Sigma)
containing 5% fetal bovine serum and 5% horse se-
rum [6]. For staining of internalized Tat-H3 into the
cells, PC12h cells (1U105 cells/cm2) were plated on a
collagen coated cultured dish. Two days after plating
the cells, 0.3 WM Tat-H3 or H3 was added to the
culture medium. After 10 min incubation, the me-
dium was washed out, and these cells were ¢xed
with 4% paraformaldehyde (PFA) for 10 min, fol-
lowed by 100% cold methanol treatment. These cells
were further incubated with 0.1% Triton X-100 con-
taining 4% PFA solution. These cells were then in-
cubated with anti-His antibody. To visualize the in-
ternalized protein, DAB was used for a substrate of
HRP conjugated anti-rabbit IgG and the cells were
observed microscopically. Fluorescent of GFP was
visualized with an inverted microscope.
2.5. ELISA
To study the time course of Tat fusion protein
internalization, cells were cultured on collagen
coated 96-well plates. Two days after plating the
cells, 0.3 WM Tat-H3 was added to each well. After
an appropriate incubation, the cells were ¢xed with
4% PFA solution. These cells were then incubated
with anti-His antibody with or without 0.1% Triton
X-100 containing 4% PFA solution. To detect inter-
nalized protein quantitatively, 3,3P,5,5P-tetramethyl-
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benzidine (TMBZ) was used as a substrate for HRP
conjugated anti-rabbit IgG. Each well was analyzed
by densitometric measurement at 450 nm.
2.6. Immunoblotting
Tat-H3 or H3 treated PC12 cells were homoge-
nized in PBS. After the nuclear pellet was removed
by centrifugation, the supernatant was further centri-
fuged at 100 000Ug for 1 h. The pellets (membrane
fraction) were resuspended in a volume of PBS equal
to that of the supernatant (cytosol fraction). These
protein fractions were subjected to SDS^polyacryl-
amide gel electrophoresis (SDS^PAGE) and visual-
ized by immunoblotting with the anti-H3 antibody.
2.7. Release assay
Two days before the experiments, PC12h cells
(5U105 cells/well) were plated on collagen coated
24-well plates [12]. To measure noradrenaline (NA)
release, PC12 cells were preloaded with 25 nM
[3H]NA (Amersham Pharmacia Biotech) for 3 h.
Then, the cells were incubated with Tat fusion pro-
tein. After an appropriate incubation, the culture
medium was washed out. Then, the medium was re-
placed with HBSS four times every 5 min, and these
fractions were collected to measure constitutive re-
lease. The cells were stimulated with 0.1 mM carba-
chol (CCh)/HBSS or high K solution (114 mM
NaCl, 30 mM KCl, 1.25 mM KH2PO4, 1 mM
MgSO4, 1.2 mM CaCl2, 2 mM NaHCO3, 10 mM
glucose, 5 mM HEPES pH 7.4) for 5 min (stimulated
release). After collecting the medium, the cells were
lysed with 0.1 N HCl to measure the [3H]NA remain-
ing in the cells. The amount secreted was calculated
as a percentage of the total radioactivity given by the
sum of the remaining and secreted [3H]NA. The
amount of release with CCh or K stimulation was
calculated as the di¡erence between constitutive re-
lease and stimulated release.
Dopamine (DA) release was assayed by high per-
formance liquid chromatography with an electro-
chemical detector [12]. The amount of secretion
was calculated as a percentage of the total DA con-
tent. The amount of release with 0.1 mM CCh or K
stimulation was calculated as the di¡erence between
constitutive release and stimulated release.
3. Results
3.1. Tat fusion protein was internalized into
PC12 cells
In order to test whether Tat PTD mediated protein
internalization occurred, PC12 cells were incubated
with recombinant fusion protein. As seen in Fig. 1A,
Tat-GFP was internalized into most PC12 cells with-
in 10 min, but this was not observed with GFP treat-
ment alone (Fig. 1B). PC12 cells were also incubated
with Tat PTD fused to the H3 domain of HPC-1/
syntaxin 1A (Tat-H3), which is known to bind to
other SNARE proteins and to suppress transmitter
Fig. 1. Internalization of Tat fusion protein. PC12 cells were in-
cubated with 0.3 WM Tat-GFP (A), GFP (B), Tat-H3 (C) or
H3 (D) for 10 min. Tat fusion was internalized into most PC12
cells. (E) PC12 cells were incubated with 0.3 WM Tat-H3 or H3
for 30 min. These cells were homogenized in PBS, and mem-
brane (lanes 1 and 3) and cytosolic fractions (lanes 2 and 4)
were prepared. These fractions were subjected to SDS^PAGE
and immunoblotting was performed. Tat-H3 protein was de-
tected in the membrane (lane 1) and cytosolic (lane 2) fractions,
but H3 protein was not detected (lanes 3 and 4).
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release in intact cells [13]. Immunohistochemical
study showed that Tat-H3 was also rapidly internal-
ized (Fig. 1C), but this was not observed with H3
treatment alone (Fig. 1D). Since this signal was not
observed without permeabilization by Triton X-100
before incubation with the antibody (data not
shown), it was thought that Tat-H3 was certainly
internalized into the PC12 cell. Immunoblotting
also revealed the presence of internalized Tat-H3 in
both the cytosol and membrane fractions (Fig. 1E,
lanes 1 and 2), but this was not observed with H3
treatment alone (Fig. 1E, lanes 3 and 4). These re-
sults clearly showed that Tat PTD mediated protein
internalization occurred in PC12 cells.
We tried to study the time course of internalization
in detail. As seen in Fig. 2, the internalized protein
was detected within 5 min of addition of the fusion
protein. This intracellular signal was not observed
without Triton X-100 treatment. The conjugate of
IgG chemically crosslinked with the PTD peptide
was also rapidly internalized within 5 min, but IgG
alone was not internalized. A similar result was also
obtained for cultured hippocampal neurons (data not
shown). Furthermore, this internalization was dose-
dependent (data not shown). These results revealed
that Tat PTD mediated internalization occurred rap-
idly in PC12 cells and neurons.
3.2. Suppression of transmitter release in
Tat-H3 treated cells
To study whether the internalized proteins re-
mained functional, PC12 cells were incubated with
0.3 WM Tat-H3 for 18 h and labeled with [3H]NA
for 3 h. There was no di¡erence in the [3H]NA up-
take into Tat-H3 treated cells and Tat-GFP treated
controls (data not shown). These cells were stimu-
lated with high K for 5 min. The amount of
[3H]NA release with Tat-H3 treatment was signi¢-
cantly lower than with Tat-GFP or H3 treatment
(Fig. 3A). This suppressive e¡ect was also observed
in [3H]NA prelabeled cells before Tat-H3 treatment
(Fig. 5A). The suppression of [3H]NA release was
dose-dependent and the estimated concentration for
half-maximum e⁄ciency was about 0.2 WM. In order
to test whether Tat-H3 treatment suppresses Ca2-
dependent transmitter release, PC12 cells were stimu-
lated under Ca2-free conditions. As shown in Fig.
3A, the amount of [3H]NA release with the Tat-H3
treatment was not signi¢cantly di¡erent from that
with Tat-GFP or H3 treatment in Ca2-free condi-
tions. These results suggest that internalized Tat-H3
remained functional in PC12 cells.
We further examined whether another HPC-1/syn-
taxin 1A fragment a¡ected transmitter release in
PC12 cells. Treatment of Tat PTD fused with
HPC-1/syntaxin 1A fragments other than H3 did
not show signi¢cant e¡ects on [3H]NA release (Fig.
3C), indicating that the suppressive e¡ect was speci¢c
to the H3 domain. A similar result was also obtained
with CCh stimulation (data not shown).
In order to examine the e¡ect of endogenous
transmitter release, DA release was measured in
Tat-H3 treated PC12 cells. DA release from Tat-H3
treated PC12 cells was signi¢cantly lower than with
Tat-GFP or H3 treatment (Fig. 3B). Under Ca2-
free conditions, DA release from the Tat-H3 treated
cells was not signi¢cantly di¡erent from the release
from Tat-GFP treated cells. These results indicated
Fig. 2. Tat fusion protein was rapidly internalized. PC12 cells
were cultured on collagen coated 96-well plates. 0.3 WM Tat-H3
was applied to these cells for 0^180 min. After ¢xation with 4%
PFA, the cells were treated with (R) or without (8) 0.1% Tri-
ton X-100. The internalized Tat-H3 was detected within 5 min.
Internalization was not observed with 0.3 WM H3 treatment
(data not shown). Internalization was also observed within
5 min with Tat-IgG treatment (F), but not with IgG treatment
(b). The data represent the mean þ S.D. of six independent ex-
periments.
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that Tat-H3 treatment suppressed Ca2-dependent
DA release.
We next examined the e¡ect of Tat-H3 on exocy-
tosis with 0.1 mM CCh stimulation. As shown in
Fig. 4A, the amount of [3H]NA released from Tat-
H3 treated PC12 cells was signi¢cantly lower than
with Tat-GFP or H3 treatment. DA release with
CCh stimulation in Tat-H3 treated PC12 cells was
also signi¢cantly lower compared with Tat-GFP or
H3 treatment (Fig. 4B).
3.3. Modi¢cation of the suppressive e¡ect of Tat-H3
by prestimulation
As shown in Fig. 1B, Tat fusion protein was rap-
idly internalized. In order to study whether the sup-
pressive e¡ect of Tat-H3 treatment also occurred
rapidly, we examined the time course of the Tat-H3
e¡ect on the release of [3H]NA. Although Tat-H3
was internalized within 5^10 min, suppression of
[3H]NA release was not observed until 30 min (Fig.
Fig. 3. Transmitter release was suppressed by Tat-H3 treatment. (A) PC12 cells were treated with 0.3 WM Tat fusion protein for 18 h.
PC12 cells without fusion protein treatment were used as controls. These cells were incubated with 25 nM [3H]NA for 3 h and stimu-
lated with K. The amount of [3H]NA released in Tat-H3 treated cells was signi¢cantly lower compared with control or Tat-GFP
treatment. This suppressive e¡ect was not observed in Ca2-free conditions. The data represent the mean þ S.D. of six independent ex-
periments. (B) 0.3 WM Tat fusion protein treated PC12 cells were stimulated with high K solution. The amount of DA released was
also suppressed by Tat-H3 treatment. This suppressive e¡ect was not observed under Ca2-free conditions. The data represent the
mean þ S.D. of three independent experiments. (C) PC12 cells were incubated with 0.3 WM HPC-1/syntaxin 1A fragments for 18 h.
Only Tat-H3 treatment suppressed [3H]NA release, while treatments with other fusion proteins had no e¡ect. Treatment with H3 not
fused to Tat PTD peptide also did not in£uence [3H]NA release. The data represent the mean þ S.D. of three independent experi-
ments.
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5A). The maximal e¡ect of Tat-H3 treatment ap-
peared after 3 h. It was thought that the suppressive
e¡ect was caused by inhibition of SNARE complex
formation by Tat-H3. Assuming that Tat-H3 only
binds to newly synthesized or disassembled SNARE
protein, the suppressive e¡ect might be delayed after
Tat-H3 internalization. According to this assump-
tion, enhancement of SNARE complex disassembly
could modify the time course of the Tat-H3 e¡ect.
To examine this possibility, Tat-H3 was washed out
immediately after the ¢rst stimulation, and a second
stimulation was applied (Fig. 5B). With the ¢rst
stimulation, there was no di¡erence in release be-
tween Tat-H3 treatment and the control. However,
with the second stimulation, [3H]NA release with
Tat-H3 treatment was signi¢cantly lower than that
of the control. This supported the hypothesis that the
¢rst stimulation enhances SNARE complex disas-
Fig. 5. Time course of [3H]NA release suppression by Tat-H3
treatment. (A) [3H]NA prelabeled PC12 cells were treated with
0.3 WM Tat fusion protein for 0^180 min. These cells were
stimulated with high K solution. The suppressive e¡ect of
Tat-H3 treatment was observed after 60 min. The data repre-
sent the mean þ S.D. of eight independent experiments. (B)
[3H]NA prelabeled PC12 cells were incubated with 0.3 WM Tat
fusion protein for 5 min. These cells were stimulated with high
K solution for 5 min (¢rst stimulation). After the ¢rst stimula-
tion, the medium was exchanged with normal HBSS and the
cells were incubated for 10 min. Then, a second stimulation
was applied. The amount of [3H]NA released at the ¢rst stimu-
lation did not di¡er between Tat-H3 treatment and the control.
At the second stimulation, the amount of [3H]NA released in
the Tat-H3 treatment was signi¢cantly lower compared with the
control. The data represent the mean þ S.D. of eight independ-
ent experiments.
Fig. 4. Tat-H3 treatment also suppressed transmitter release
with CCh stimulation. PC12 cells were incubated with 0.3 WM
Tat fusion protein for 18 h; these cells were stimulated with 0.1
mM CCh. The amount of [3H]NA (A) or DA (B) released was
measured. The release of these transmitters was also suppressed
by Tat-H3 treatment as in the case of high K stimulation.
The data represent the mean þ S.D. of four independent experi-
ments.
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sembly and that Tat-H3 inhibits the assembly of new
complexes during the second stimulation.
4. Discussion
In this study, we used a new protein introducing
method mediated by Tat PTD. As seen in Fig. 1A,C,
the Tat fusion protein was internalized with high
e⁄ciency. This internalization occurred rapidly
(Fig. 2). Furthermore, the amount of internalized
protein and the e¡ect of Tat-H3 were dose-depen-
dent (Fig. 5A). A similar result was observed in cul-
tured hippocampal neurons (data not shown). These
results showed that Tat PTD mediated protein inter-
nalization occurred in PC12 cells and neurons.
It has been reported that a HIV Tat protein is
neurotoxic [14,15]. Although transmitter release was
suppressed with 0.3 WM Tat-H3 treatment, applica-
tion of Tat-GFP or Tat-H3 did not a¡ect the viabil-
ity of PC12 cells or cultured hippocampal neurons
(data not shown). Accordingly, it was thought that
the e¡ective concentration of Tat-H3 used to sup-
press transmitter release was too low to cause cell
toxicity. These results suggest that this protein intro-
ducing method is a useful tool for the molecular
analysis of neurotransmitter release in intact cells.
The internalized Tat-GFP or Tat-IgG remained in
cells at least 1 h after washing out the medium, but it
became undetectable after 6 h (data not shown). The
internalized protein was quickly lost, although it was
not clear whether it leaked from the cell or was de-
graded in the cell. The suppressive e¡ect of Tat-H3
treatment prolonged retention for at least 4 h after
washing out the medium (Fig. 3). These results sug-
gested that internalized Tat-H3 might bind to
SNARE proteins in PC12 cells.
As seen in Fig. 3C, Tat HPC-1/syntaxin 1A frag-
ment fusion proteins other than H3 did not a¡ect
transmitter release in PC12 cells. Although Tat-
N265 contained the H3 domain, Tat-N265 treatment
did not a¡ect [3H]NA or DA release. This suggests
that the N-terminus of HPC-1/syntaxin 1A contains
a regulatory region [13,17]. Since Tat-N201 contains
the N-terminus and lacks H3, the results of Tat-
N201 treatment suggest that the N-terminal region
of HPC-1/syntaxin 1A regulates the H3 domain.
However, further study is necessary to assess this
hypothesis.
Although the internalization occurred rapidly (Fig.
2), suppression of transmitter release by Tat-H3
treatment did not occur for 30 min (Fig. 5A). There
are two explanations for this discrepancy. First, it is
possible that the internalized Tat-H3 is not a cyto-
solic component and that Tat-H3 is internalized in
endosomes and then gradually released into the cy-
tosol. Second, Tat-H3 might be directly internalized
into the cytosol, but since SNARE proteins form a
stable complex in the cell, the internalized Tat-H3
might not a¡ect complexes already formed. As
shown in Fig. 5B, the suppression of transmitter re-
lease was observed 5 min after Tat-H3 treatment
with previous stimulation. This result supports the
latter hypothesis, since it has been reported that dis-
assembly of formed SNARE complexes occurs dur-
ing exocytosis [16]. If internalized Tat-H3 inhibited
the assembly of new complexes, suppression of trans-
mitter release would occur during the second stimu-
lation.
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